| Literature DB >> 12973396 |
Y Sherer1, Y Levy, F Fabrizzi, Y Shoenfeld.
Abstract
Intravenous immunoglobulin (IVIg) is currently an accepted treatment for some autoimmune diseases and it has recently been used empirically in various other autoimmune conditions. This review discusses the role of IVIg in autoimmunity, mainly in systemic lupus erythematosus and systemic vasculitis. Clinical experience with IVIg, as well as its mechanisms of action with special emphasis on modulation of the idiotypic network, are also presented. (c) 1999 Prous Science. All rights reserved.Entities:
Year: 1999 PMID： 12973396 DOI： 10.1358/dot.1999.35.7.548264
Source DB: PubMed Journal: Drugs Today (Barc) ISSN： 1699-3993 Impact factor: 2.245